等离子双极电切技术在前列腺增生患者中的应用研究
[Abstract]:Part 1 a comparative study of the effects of domestic and imported plasma bipolar electrotangent rings on the histopathology of prostatic prostate in dogs. Objective: To compare the histopathological effects of domestic and imported plasma bipolar rings on the histopathology of the prostate in dogs. Methods: 18 adult male hybrid dogs were randomly divided into 2 groups: the imported electric cutting ring group (9), and the domestic electric cut ring group (9 0 after the operation (immediately after the operation), the animals were sacrificed at 1,6 weeks and the prostate specimens were obtained. The pathological changes of the prostate tissue were observed under the light microscope and the thickness of the solidified layer of the wound was measured. Results: the thickness of the coagulation layer of the prostate tissue in the imported electric cutting ring group and the domestic electric cutting ring group was (235.45 + 25.37) mu m respectively, (110.87 +). 20.23) mu m and (238.12 + 32.47) mu m, (112.64 + 18.76) mu m, there was no significant difference in the two groups after the operation (P0.05). 6 weeks after the operation, the coagulation layer of the wound surface of the prostate tissue in the imported electric cutting ring group and the domestic electrocut ring group was completely off, and the wound was covered with the regenerated urinary tract epithelium. After 0,1,6 weeks after the operation, the imported electric cutting ring group and the domestic electric cutting ring group were in the forefront. The adenoid tissues have different degrees of inflammation, the dilatation of the lumen and the destruction of the epithelium under the solidified layer. Conclusion: the pathological effects of the imported electrotangent ring and the domestic electrotangent ring on the wound of the prostate tissue are basically similar. The application of second parts of the prostatic plasma bipolar electrocutting technique in the treatment of large volume prostatic hyperplasia (80g) Objective: To study the application and clinical effect of transurethral prostatic plasma bipolar electrosurgical resection (PKRP) in patients with prostatic hyperplasia (prostate volume greater than 80g) and to compare the therapeutic effect of PKRP on patients with different prostate volumes. Methods: a retrospective analysis of the prostatic hyperplasia in the Department of Urology of our hospital in December January 2011 after the treatment of PRKP in the Department of urology. The basic information of the patients (prostate volume greater than 80g) was collected, including preoperative parameters (age, size of the prostate, Qmax, residual urine, IPSS, fPSA, fPSA blood Hb, blood Na+) and postoperative index (hospitalization days (H), operation time (min), catheterization time, reoperation, or blood transfusion) at the same time according to the volume of the prostate. Two groups: 80-100g and 100g. Through the above two groups of age, the size of the prostate, Qmax, residual urine, IPSS, fPSA, fPSA, blood Hb, blood Na+, the days of hospitalization (H), operation time (min), tube time and other results were carried out t test and statistical analysis, the difference between the two groups of the two groups was statistically significant. 40 patients were treated with PKRP, and the pathological report of.40 PKRP after operation was benign prostatic hyperplasia. The age of the patients treated with PKRP was (72.3 + 6.65) years old. The size of the prostate was (101.05 + 18.78) g, Qmax (7.25 + 2.62) ml/s, residual urine volume (131.09 + 139.63) ml, IPSS (19.97 + 7.12), Total PSA (13.11 + 12.31) ng/. L, f/t PSA (0.226 + 0.082), preoperative Hb (129.65 + 11.58) g/L, preoperative blood Na+ (141.34 + 2.62) mmol/L, total operation time (112 + 40.62) min, resection weight (60 + 17.02) g, hospitalization time (25.475 + 8.464) days, and catheterization time (166.05 + 91.09) H. after surgery for bleeding and reoperation. After transurethral resection of the prostate, the patients with adenosine hyperplasia showed that the 80-100g prostatic group (n=23) and the prostate group above 100g (n=1 7) were excised (51.52 + 11.02g vs.71.47 + 17.21g) after PKRP, and the number of hospitalized days (23.17 + 7.50d vs.28.59 +. 8.91d), and the number of reoperations (0 vs.1) and the number of blood transfusion (0) had significant statistical differences. P0.05).35 patients were followed up by telephone. The follow-up time was 5-17 months after the operation, and the IPSS score was 2.51 + 1.15. Only one case had a slightly worse erectile function than before the operation. No patients needed reoperation after discharge. No patients had urinary incontinence, 7 patients had retrograde ejaculation and 20 cases of urinary tract infection. Conclusion: PKRP was used to treat the large volume of prostate. The prostatic hyperplasia at 80g is safe and effective. By using saline as an intraoperative irrigation fluid, it clearly eliminates the risk of TUR syndrome and has no obvious effect on sexual function..PKRP is a promising form for the treatment of the large prostate. It should be more popularized and applied in the Department of urology. The third part of the Bcl-2 protein expression should be expressed. Meta analysis of the risk of prostate cancer risk in Chinese people: use the NETA analysis method to systematically evaluate the correlation between Bcl-2 protein expression and the different clinicopathological features of prostate cancer in Chinese population. Methods: PubMed, Embase, CBM, CNKI, VIP and WanFang Data databases were retrieved by computer to search for the expression of Bcl-2 protein. A case-control study on the correlation between prostate cancer and its different clinicopathological features in Chinese people, the retrieval time was from the establishment of the library to March 2016. 2 evaluators were selected independently, the data extraction and the methodological quality evaluation, and then the RevMan 5.3 software for Meta analysis. Results: the final inclusion of 24 case control studies, Among the 1081 cases of prostate cancer and 178 cases of normal prostate control, the results of.Meta analysis showed that the expression of Bcl-2 protein in prostate cancer patients was higher than that of [OR=3.27,95%CI (1.68,6.38), P=0.0005], and [OR=3.77,95%CI (1.81,7.88) and P=0.0004], and the difference was statistically significant higher than that of normal prostate control; in prostate cancer, the prostate cancer was statistically significant. The expression of Bcl-2 protein in low differentiation group was higher than that of high group [OR=3.60,95%CI (2.51,5.16), P0.00001]. The expression of Bcl-2 protein in J-W-P stage group C+D group was higher than that of A+B stage group [OR=2.17,95%CI (1.23,3.84), P=0.008], and the expression of Bcl-2 protein in prostate cancer group was higher than that of non metastasis group. Conclusion: there is a significant correlation between the expression of Bcl-2 protein and the prostatic cancer and its clinicopathological features in Chinese population. The above conclusions need to be further developed and verified by high quality research. The fourth part of E-cadherin expression is related to the risk of prostate cancer in Chinese population. Meta analysis objective: to systematically evaluate the correlation between E-cadherin expression and the different clinicopathological features of prostate cancer in Chinese population by NETA analysis. Methods: the database of PubMed, Embase, CBM, CNKI, VIP and WanFang Data was retrieved by computer to collect the expression of prostate cancer and its different clinical diseases in Chinese population. The clinical study of the correlation of physical characteristics was from the establishment of the library to December 2015. The 2 evaluators were selected and extracted independently according to the exclusion criteria. Then the Meta analysis was carried out by RevMan5.3 software. Results: the results were included in 21 studies, including 920 cases of prostate cancer, 415 cases of prostatic hyperplasia and normal prostate. The results of.Meta analysis in 48 cases of tissue group showed that the expression of E-cadherin in prostate cancer group was significantly lower than that of [OR=0.07,95%CI (0.05,0.11), P0.01] and normal prostate tissue [OR=0.04, 95%CI (0.01,0.18), P0.01], and the expression of E-cadherin in prostate cancer tissue was increased with the pathological grading and clinical stage of prostate cancer. Conclusion: there is a significant correlation between the low expression of E-cadherin and the clinicopathological characteristics of prostate cancer in Chinese population and its clinicopathological features. The conclusion needs further high quality research to be verified. The fifth part of the expression of Survivin protein and the expression of Survivin protein in the Chinese population Meta analysis of the risk related prostate cancer risk in Chinese people: Meta analysis was used to evaluate the correlation between the expression of Survivin protein and the different clinicopathological features of prostate cancer in Chinese population. Methods: the database of PubMed, Embase, CBM, CNKI, VIP and WanFang Data was retrieved by computer to search for the expression of Survivin protein and China A case control study of the correlation between prostate cancer and its different clinicopathological features was studied. The retrieval time was from the establishment of the library to November 2015. 2 authors were screened independently by the inclusion criteria, the data extraction and the quality evaluation were evaluated, and the RevMan 5.3 software was used for the Meta analysis. The results were included in the final 32 cases. In the control study, 1613 cases of prostate cancer, 708 cases of prostatic hyperplasia and 93 cases of normal prostate tissue group.Meta analysis showed that the expression of Survivin protein in prostate cancer group and prostatic hyperplasia group [OR=32.95,95%CI (19.88,54.63), P0.01], prostate cancer group and normal prostatic gland group [OR=75.78,95%CI (26.97212.98), P0.01] expression. The differences were statistically significant, Survivin protein in the low differentiation group and the high group [OR=4.45,95%CI (3.13,6.32), P0.01], J-W-P stage C+D group and A+B stage [OR=5.42,95%CI (2.91,10.10), P0.01], lymph node metastasis group and no lymph node metastasis group [OR=4.07,95%CI (2.91,10.10), differences in expression. Conclusion: there is a significant correlation between the expression of Survivin protein and the prostatic cancer and its clinicopathological features in Chinese population.
【学位授予单位】:武汉大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R699.8
【相似文献】
相关期刊论文 前10条
1 王化锋;经尿道前列腺汽化电切术治疗前列腺增生症[J];山东医药;2000年03期
2 邹志琨,吕俊江;痔与前列腺增生的关系[J];山东医药;2000年09期
3 钟文乐,饶桂兰;前列腺增生机理概述[J];井冈山医专学报;2000年04期
4 杨小华,邹永康,刘乔保;经尿道前列腺电切术治疗青壮年前列腺增生症[J];临床泌尿外科杂志;2000年04期
5 佟强;大黄釳虫丸治疗前列腺增生症38例[J];天津中医学院学报;2000年04期
6 王健;中药可抑制前列腺增生[J];中国乡村医生;2000年08期
7 刘筱琴;前列腺增生患者健康教育的需求[J];广东医学;2001年06期
8 何映;前列腺增生症治疗小议[J];江苏中医;2001年12期
9 权浩锡,杨轶凡,梁玉林,杨巍;经尿道气化电切术治疗前列腺增生57例临床分析[J];北华大学学报(自然科学版);2002年04期
10 刘建平,曲宏,闫宏亮,王凤华;重度前列腺增生经尿道气化电切术治疗体会(附78例报告)[J];临床泌尿外科杂志;2002年07期
相关会议论文 前10条
1 张国梁;;前列腺汽化电切术为中老年前列腺增生患者开辟了一条绿色通道[A];中国老年学学会2006年老年学学术高峰论坛论文集[C];2006年
2 陈潮洪;严春中;楼冬玲;杨照;王海霞;王玲玲;李旭;;耻骨后前列腺摘除术治疗前列腺增生80例[A];2007年浙江省男科学学术年会论文汇编[C];2007年
3 陈潮洪;严春中;楼冬玲;杨照;王海霞;王玲玲;李旭;;耻骨后前列腺摘除术治疗前列腺增生80例[A];中华医学会第八次全国男科学学术会议论文集[C];2007年
4 孟作为;;吸烟对前列腺增生症的影响[A];中华医学会第八次全国男科学学术会议论文集[C];2007年
5 孙兴纯;王平;毛杰;张云恭;王益;张福坤;;经尿道等离子双极电切术治疗29例前列腺增生症体会[A];第十五届全国泌尿外科学术会议论文集[C];2008年
6 高筱松;张亚强;;2微米激光前列腺汽化切割术治疗前列腺增生症疗效观察[A];第七次中国中西医结合泌尿外科学术年会暨第二次广东省中西医结合泌尿外科学术年会论文集[C];2009年
7 林凯臣;王华伍;王苹;王泽敏;陈锐平;蔡伯基;王建才;;性活动与前列腺增生症的相关研究[A];新编男科理论与临床——中华中医药学会第七届中医男科学术大会;全国中医男科临床与科研方法高级研修班;2006年云南省中医男科诊疗技术培训班讲义与论文集[C];2006年
8 郭和清;周高标;潘广新;穆大为;孙斌;刘永胜;邢继章;刘洪明;李迪;严景民;洪泉;;重度前列腺增生经尿道气化电切术[A];第十七届全国泌尿外科学术会议论文汇编[C];2010年
9 贾金铭;孔令青;;前列腺增生症的现代诊治进展[A];第一届全国中西医结合男科学术会议论文汇编[C];2001年
10 徐霞;;老年前列腺增生患者的心理护理体会[A];全国第五届老年护理学术交流暨专题讲座会议论文汇编[C];2002年
相关重要报纸文章 前10条
1 长沙星灿泌尿微创专科医院副主任医师 刘跃光;治疗前列腺增生症的金标准[N];大众卫生报;2006年
2 白云;前列腺增生会变成癌吗?[N];民族医药报;2006年
3 副主任医师 徐文端;疝气对前列腺增生有影响吗[N];卫生与生活报;2007年
4 刘申安;前列腺增生四问[N];医药养生保健报;2008年
5 中国中医科学院西苑医院男科 张牧川;葱蒜可防前列腺增生[N];健康时报;2008年
6 本报记者 钟思思;预防前列腺增生从青壮年做起[N];保健时报;2004年
7 陈志春;哪些药治疗前列腺增生效果好[N];健康报;2004年
8 董兴刚(上海市第二医院 副主任医师);前列腺增生症知识五问[N];上海中医药报;2004年
9 冯瑶 顾德宁;前列腺增生不要盲目“减肥”[N];新华日报;2005年
10 秦宁;前列腺增生症的治疗[N];云南科技报;2003年
相关博士学位论文 前10条
1 黄静宇;等离子双极电切技术在前列腺增生患者中的应用研究[D];武汉大学;2016年
2 翁寿雍;中医药治疗前列腺增生症的研究[D];南京中医药大学;2006年
3 顾欣;单核苷酸多态性预测前列腺增生发病风险及药物疗效的研究[D];上海交通大学;2014年
4 陈震刚;温针结合中药治疗慢性前列腺增生的临床研究[D];广州中医药大学;2010年
5 邱云桥;前列腺增生症中医证型与相关因素分析[D];广州中医药大学;2005年
6 蒋玉清;热休克蛋白及促炎症细胞因子在前列腺增生合并前列腺炎发生中相关机制的研究[D];河北医科大学;2014年
7 徐忠华;第一部分 前列腺增生症患者膀胱逼尿肌神经生长因子及其受体的变化和意义 第二部分 腹腔镜在泌尿外科的临床应用[D];山东大学;2005年
8 祝常德;益肾通胶囊治疗前列腺增生的临床观察与实验研究[D];广州中医药大学;2014年
9 王龙;白细胞介素-2对前列腺增生上皮细胞增殖、凋亡及旁分泌的影响[D];中南大学;2009年
10 赵建业;三虫合剂对前列腺增生症大鼠模型激素水平及KI-67、VEGF表达的影响[D];湖南中医药大学;2011年
相关硕士学位论文 前10条
1 崔涛;经尿道前列腺等离子电切术后出血病人的观察与防治对策[D];泰山医学院;2014年
2 赵力;TURP治疗大体积前列腺增生(≥80ml)安全性及有效性的前瞻性对照研究[D];第三军医大学;2015年
3 闫振;两种手术方式治疗前列腺增生的有效性和安全性研究[D];新疆医科大学;2015年
4 朱千三;中药补肾活血对前列腺增生大鼠膀胱逼尿肌的影响及机制的研究[D];浙江中医药大学;2013年
5 施萍;前列腺增生患者术前自我管理效能感及影响因素研究[D];辽宁医学院;2015年
6 郭辉;油菜蜂花粉含片研制及其抗前列腺增生作用研究[D];福建农林大学;2013年
7 李峗;戴恩来教授辨治前列腺增生症的临床经验总结[D];甘肃中医药大学;2016年
8 赵凡;前列通窍胶囊对前列腺增生大鼠膀胱逼尿肌Bax和Bcl-2表达的影响与临床观察[D];云南中医学院;2016年
9 于慕渊;国产绿激光与国产2μm激光治疗前列腺增生症的对比研究[D];苏州大学;2016年
10 董晴;抗前列腺增生中药复方WDD活性部位筛选及作用机制研究[D];哈尔滨理工大学;2016年
,本文编号:2137117
本文链接:https://www.wllwen.com/yixuelunwen/mjlw/2137117.html